EP Patent

EP0773226A1 — Propiophenone derivative and processes for preparing the same

Assigned to Tanabe Pharma Corp · Expires 1997-05-14 · 29y expired

What this patent protects

A propiophenone derivative the formula [ ]: wherein R' is a lower alkanoyl group and R'' is a hydrogen atom, or R' is a hydrogen atom and R'' is a lower alkoxycarbonyl group, or a pharmaceutically acceptable salt thereof. Said compounds have excellent hypoglycemic activity …

USPTO Abstract

A propiophenone derivative the formula [ ]: wherein R' is a lower alkanoyl group and R'' is a hydrogen atom, or R' is a hydrogen atom and R'' is a lower alkoxycarbonyl group, or a pharmaceutically acceptable salt thereof. Said compounds have excellent hypoglycemic activity so that they are useful in the prophylaxis or treatment of diabetes.

Drugs covered by this patent

Patent Metadata

Patent number
EP0773226A1
Jurisdiction
EP
Classification
—
Expires
1997-05-14
Drug substance claim
No
Drug product claim
No
Assignee
Tanabe Pharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.